Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa
Clinical trial NCT04315025 · COMPLETED
Trial details
- NCT number
- NCT04315025
- Sponsor
- PT. Prodia Stem Cell Indonesia
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-07
- Primary completion
- 2019-06-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.